Study guide

Outflow and the Goldmann pressure model

European Board of Ophthalmology Diploma EBOD

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: EBOD Examination, Applications and Regulations

EBOD Format, Scoring and Revision Planning Eligibility, Applications and the Diploma Online Rules, Technical Preparation and Appeals

2 Chapter 2: Physical Optics, Photometry and Lenses

Light, refraction and total internal reflection Photometry, contrast, colour and adaptation Prisms, decentration and vector combination Vergence, astigmatic lenses and Sturm’s conoid

3 Chapter 3: Instrument Optics, Aberrations and Laser Physics

Cross-cylinder and diagnostic instrument optics Aberrations, duochrome and wavefront analysis Diffraction, polarization, lasers and OCT

4 Chapter 4: Refraction, Accommodation and Spectacle Prescribing

Objective and cycloplegic refraction Subjective refraction and binocular balance Accommodation, presbyopia and vertex distance Spectacle Materials, Measurement and Progressive Lenses

5 Chapter 5: Contact Lenses and Low-Vision Rehabilitation

Contact-lens optics, materials and tear lenses Contact-lens fit and complications Low-vision assessment and magnification Low-vision aids, calculations and ergonomics

6 Chapter 6: Extraocular Anatomy and Motor Physiology

Extraocular muscle anatomy and innervation Eye axes, kinematics and muscle actions Motor laws and orbital pulleys

7 Chapter 7: Binocular Vision and Amblyopia

Binocular vision, stereopsis and the horopter Suppression, correspondence and microtropia Sensory tests and amblyopia treatment

8 Chapter 8: Childhood Assessment and Strabismus Testing

Visual Development, Childhood Testing and Developmental Delay History, corneal reflexes and cover tests Motility patterns, three-step testing and Hess charts

9 Chapter 9: Esotropia, Exotropia and Vertical Deviations

Infantile and accommodative esotropia Exotropia classification and management Vertical Deviations, A–V Patterns and Skew

10 Chapter 10: Dysinnervation, Nystagmus and Muscle Surgery

Duane syndrome, Brown syndrome and restriction Nystagmus patterns and investigation Nystagmus and muscle surgery principles

11 Chapter 11: ROP and Paediatric Ocular Disease

Retinopathy of Prematurity: Screening, Classification and Follow-up Childhood Cataract, Leukocoria and Congenital Glaucoma Childhood Systemic Disease, Infection and Safeguarding

12 Chapter 12: Ocular Surface Anatomy and Infection

Corneal, Conjunctival and Scleral Structure: Examination and Sampling Bacterial keratitis, sampling and treatment Fungal, amoebic and herpetic keratitis Infectious, chlamydial and neonatal conjunctivitis

13 Chapter 13: Allergy, Cicatrisation and Surface Inflammation

Allergic eye disease, trachoma and phlyctenules Cicatrising Conjunctivitis: Mucous Membrane Pemphigoid and SJS/TEN Dry eye, blepharitis and meibomian dysfunction PUK, interstitial keratitis and scleritis

14 Chapter 14: Anterior Segment Dysgenesis and Corneal Dystrophies

Anterior Segment Dysgenesis, Aniridia and Congenital Corneal Opacity IC3D and epithelial or Bowman-layer dystrophies Stromal corneal dystrophies Endothelial corneal dystrophies

15 Chapter 15: Corneal Degeneration, Ectasia and Epithelial Failure

Corneal Degenerations, Pterygium, Band Keratopathy and Dellen Keratoconus and clinical ectasia signs Ectasia imaging, cross-linking and rehabilitation Recurrent Erosion, Neurotrophic Keratopathy and Vitamin A Deficiency

16 Chapter 16: Surface Reconstruction and Keratoplasty

Limbal Stem-Cell Failure, Tarsorrhaphy and Phototherapeutic Keratectomy PK, DALK and endothelial keratoplasty Corneal graft immunity and rejection recognition Graft rejection treatment and postoperative problems

17 Chapter 17: Lens Development, Cataract Assessment and Biometry

Lens Development, Congenital Shape and Ectopia Lentis Lens anatomy and age-related cataract phenotypes Cataract grading, secondary causes and childhood disease Optical and ultrasound biometry

18 Chapter 18: IOL Planning and Phacoemulsification

Keratometry and IOL power formulae Post-refractive biometry, toric alignment and IOL design Phaco fluidics and ultrasound delivery Wounds, OVDs and nucleus techniques

19 Chapter 19: Cataract Anaesthesia and Surgical Complications

Cataract Anaesthesia, Alternative Extraction and Combined Procedures IFIS, capsule rupture and compromised support Postoperative inflammation, haemorrhage and PCO

20 Chapter 20: Corneal and Intraocular Refractive Surgery

Excimer ablation, PRK and LASIK SMILE, surgical selection and complications Phakic IOLs and refractive lens exchange

21 Chapter 21: Presbyopia Procedures and Surface Therapeutics

Presbyopia Surgery, Monovision and Historical Refractive Procedures Surface antimicrobial and anti-inflammatory pharmacology Surface healing, amnion and cenegermin

22 Chapter 22: Aqueous Dynamics, Tonometry and Gonioscopy

Ciliary body and aqueous secretion Outflow and the Goldmann pressure model Tonometry, corneal thickness and biomechanics Gonioscopy optics, landmarks and indentation

23 Chapter 23: Angle, Disc and Visual-Field Assessment

Angle grading and anterior-segment imaging Optic-disc examination and documentation OCT and automated perimetry

24 Chapter 24: Glaucoma Progression, Suspects and Secondary Mechanisms

Field reliability and progression Ocular hypertension, suspects and juvenile glaucoma Lens-related glaucoma, aqueous misdirection and venous pressure

25 Chapter 25: POAG, Angle Closure and Pigmentary Disease

POAG, target pressure and normal-tension disease Angle-closure classification and mechanisms Acute angle closure, iridotomy and lens extraction Pseudoexfoliation and pigmentary glaucoma

26 Chapter 26: Glaucoma Medical, Laser and Surgical Treatment

Neovascular, uveitic and steroid-response glaucoma Glaucoma medicines, SLT and MIGS Trabeculectomy and drainage implants Nonpenetrating surgery, cyclodestruction and postoperative lasers

27 Chapter 27: Retinal Imaging, Diabetes and Vascular Occlusion

Retinal anatomy, examination and multimodal imaging Diabetic microangiopathy and NPDR classification PDR, macular oedema and diabetic trials Retinal vein and artery occlusions

28 Chapter 28: Uncommon Vascular Disease and Myopic Maculopathy

Macroaneurysm, sickle retinopathy and retinal periphlebitis Coats disease and leukocoria assessment MacTel and radiation retinopathy Myopic maculopathy and presumed ocular histoplasmosis

29 Chapter 29: Inherited Retina and Electrophysiology

Retinitis pigmentosa and inherited degeneration Stargardt, Best disease and retinal electrophysiology Cone disorders, stationary night blindness and syndromic retina

30 Chapter 30: AMD, Geographic Atrophy and Pachychoroid

AMD biology and clinical staging Drusen, geographic atrophy and neovascular phenotypes Neovascular AMD trials and treatment CSCR and the pachychoroid spectrum

31 Chapter 31: Retinal Breaks and Detachment Repair

PVD, peripheral degenerations and retinal breaks RRD localization and retinoschisis Detachment mechanisms, pneumatic retinopexy and scleral buckling

32 Chapter 32: Vitrectomy, Macular Surgery and Retinal Trauma

Vitrectomy and intraocular tamponades ERM, macular holes and PVR Retinal trauma, optic-disc pits and choroidal detachment

33 Chapter 33: Uveitis Classification and Non-Infectious Inflammation

SUN classification, grading and uveitis work-up Anterior and intermediate uveitis patterns HLA-B27, sarcoidosis, Behçet disease and VKH Posterior inflammatory patterns and immunomodulation

34 Chapter 34: Infectious Uveitis and Endophthalmitis

Toxoplasmosis and herpetic necrotizing retinitis Ocular syphilis and tuberculosis Immunosuppressed retinitis, toxocariasis and neuroretinitis Endophthalmitis diagnosis and treatment

35 Chapter 35: Optic Neuritis and Ischaemic Optic Neuropathy

Typical optic neuritis and ONTT NMOSD and MOGAD Arteritic optic neuropathy and GCA NAION and ischaemic neuropathy comparison

36 Chapter 36: Papilloedema, IIH and Afferent Localisation

Papilloedema recognition and Frisén grading IIH diagnosis and vision protection Disc drusen and pseudopapilloedema Afferent pathways and chiasmal localization

37 Chapter 37: Congenital, Inherited and Cortical Neuro-Ophthalmology

Cortical vision and higher visual syndromes Neuro-ophthalmic testing and congenital optic discs Inherited, compressive, infiltrative and nutritional optic neuropathies Transient visual loss, headache and neurological emergencies

38 Chapter 38: Central Motor Control and Cranial Nerve Palsies

Central ocular motor control and supranuclear disorders Third- and fourth-nerve palsies Sixth nerve, pontine gaze and cavernous sinus

39 Chapter 39: Myasthenia and Ocular Myopathy

Myasthenic ocular weakness Myasthenia testing and treatment Myopathy, CPEO and Kearns–Sayre syndrome

40 Chapter 40: Pupillary Pathways and Anisocoria

Pupillary pathways and afferent defects Horner syndrome and tonic pupil Light–near dissociation and pupil differentials

41 Chapter 41: Orbit, Thyroid Eye Disease and Ptosis Assessment

Orbital anatomy and thyroid eye disease Orbital infection and idiopathic inflammation Orbital masses, approaches and eye-removal procedures Lid anatomy and ptosis evaluation

42 Chapter 42: Lid Repair and Lacrimal Drainage

Ptosis repair, malposition and eyelid tumours Lash disorders, facial palsy and lid reconstruction Lacrimal drainage and epiphora testing Nasolacrimal obstruction, infection and DCR

43 Chapter 43: Lacrimal Gland Disease, Pathology and Intraocular Tumours

Lacrimal gland inflammation and tumours Ocular histology, specimen handling and special stains Immunophenotyping, molecular pathology and tumour genetics Uveal melanoma and retinoblastoma

44 Chapter 44: Lymphoma, Surface Tumours and Paraneoplastic Disease

Vitreoretinal lymphoma Surface tumours, uveal metastases and benign mimics Paraneoplastic retinopathy, treatment effects and counselling

45 Chapter 45: Ocular Trauma and Vascular Systemic Disease

Trauma terminology and prognostic scoring Chemical injury and surface preservation Open-globe emergency management Vascular, endocrine, pregnancy and renal eye disease

46 Chapter 46: Multisystem Disease and Ophthalmic Pharmacology

Immune, metabolic and multisystem ocular clues Phakomatoses and syndrome-specific surveillance Connective-tissue and metabolic ocular disease Drug delivery and systemic glaucoma effects

47 Chapter 47: Medication Toxicity, Professional Practice and Clinical Stations

Retinal and optic medication toxicity Prevention, consent and professional practice Directed clinical answers and station rehearsal

Outflow and the Goldmann pressure model

Key Takeaways Explain This Topic AI

Conventional drainage passes through trabecular and canal pathways to downstream veins.

Uveoscleral drainage follows a different route and responds differently to muscle and drug effects.

The Goldmann equation is a model with stated assumptions, and downstream venous pressure limits its interpretation.

Last updated: October 2026

2. Aqueous Outflow Pathways: Conventional vs. Unconventional

Aqueous humour flows from the posterior chamber through the pupil into the anterior chamber, where thermal convection currents circulate fluid (downward along the cool inner corneal surface, upward along the warm anterior iris surface). Fluid then exits the anterior chamber through two anatomically and physiologically distinct routes:

1. The Conventional (Trabecular) Outflow Pathway ( 70 to 90 % 70\text{ to }90\% 70 to 90% )

The conventional route is a pressure-dependent bulk-flow system ; outflow increases linearly as intraocular pressure rises above episcleral venous pressure. The pathway comprises five sequential anatomical zones:

Uveal Meshwork: The innermost layer facing the anterior chamber recess, extending from the iris root and ciliary body band to Schwalbe's line. Formed by branching, cord-like, endothelial-covered collagen beams separated by large intercellular openings measuring 25 to 75 μ m 25\text{ to }75\,\mu\text{m} 25 to 75 μ m . It offers negligible hydraulic resistance to fluid passage.

Corneoscleral Meshwork: The intermediate layer, extending from the scleral spur to the anterior wall of the scleral sulcus. Composed of 8 to 15 8\text{ to }15 8 to 15 perforated connective tissue lamellae arranged in concentric sheets. The rounded or oval intertrabecular openings become progressively smaller toward the periphery, measuring 5 to 50 μ m 5\text{ to }50\,\mu\text{m} 5 to 50 μ m .

Juxtacanalicular Tissue (JCT / Cribriform Layer): The outermost zone ( 2 to 10 μ m 2\text{ to }10\,\mu\text{m} 2 to 10 μ m thick) directly abutting the inner wall endothelium of Schlemm's canal. Unlike the uveal and corneoscleral zones, the JCT possesses no organized collagen beams. Instead, it consists of a continuous, loosely packed extracellular matrix (composed of hyaluronic acid, chondroitin sulfate, dermatan sulfate, fibronectin, and laminin) embedded with resident juxtacanalicular cells.

The Principal Site of Outflow Resistance: Micro-cannulation studies confirm that the JCT provides over 50 to 75 % 50\text{ to }75\% 50 to 75% of total normal hydraulic outflow resistance . In primary open-angle glaucoma (POAG), pathological resistance escalates due to progressive deposition of abnormal extracellular matrix sheath material, excessive accumulation of chondroitin sulfate proteoglycans, formation of cross-linked actin networks (CLANs) in trabecular cells, and apoptosis-driven trabecular endothelial cell depletion.

Schlemm's Canal (Sinus Venosus Sclerae): A continuous circumferential endothelium-lined channel measuring 250 to 350 μ m 250\text{ to }350\,\mu\text{m} 250 to 350 μ m in cross-sectional diameter, running in the scleral sulcus. Aqueous crosses the non-fenestrated continuous inner wall endothelium via unique transcellular giant vacuoles ( 2 to 15 μ m 2\text{ to }15\,\mu\text{m} 2 to 15 μ m in diameter) and transcellular pores ( 0.5 to 2.0 μ m 0.5\text{ to }2.0\,\mu\text{m} 0.5 to 2.0 μ m ). These vacuoles form dynamically in response to trans-trabecular hydrostatic pressure gradients, bulging into the canal lumen and discharging fluid.

The Efferent Collector System & Episcleral Venous Pressure ( P e P_e P e ​ ): From the outer wall of Schlemm's canal, aqueous drains into 25 to 35 25\text{ to }35 25 to 35 collector channels of Sondermann , which anastomose with the deep intrascleral venous plexus. These empty directly into the aqueous veins of Ascher , which merge with anterior ciliary veins to form the episcleral venous plexus .

The baseline Episcleral Venous Pressure ( P e P_e P e ​ ) averages 8 to 10 mmHg 8\text{ to }10\text{ mmHg} 8 to 10 mmHg . Because fluid cannot drain down a negative hydrostatic pressure gradient through a non-collapsible venous network, P e P_e P e ​ limits pressure lowering through conventional outflow in this simplified model; other routes and changing physiology matter.

Any pathology that elevates P e P_e P e ​ —such as carotid-cavernous fistulas, dural arteriovenous malformations, Sturge-Weber syndrome (episcleral hemangiomatosis), retrobulbar tumours, thyroid eye disease, or superior vena cava syndrome—produces a direct, model-predicted 1:1 pressure rise if other parameters remain unchanged.

2. The Unconventional (Uveoscleral) Outflow Pathway ( 10 to 30 % 10\text{ to }30\% 10 to 30% )

In the unconventional pathway, aqueous exits the chamber by seeping directly into the anterior ciliary body face at the angle recess:

Anatomical Route: Fluid traverses the intercellular spaces between bundles of the longitudinal ciliary muscle, passes into the supraciliary and suprachoroidal spaces, and exits the globe through the scleral matrix, perivascular emissaria of vortex veins, and ciliary nerve channels.

Hydrodynamic Characteristics: Uveoscleral outflow is essentially pressure-independent across physiological IOP ranges ( 10 to 35 mmHg 10\text{ to }35\text{ mmHg} 10 to 35 mmHg ). Because fluid is drawn by bulk absorption into vascular beds and transscleral interstitial suction rather than forced through a filtering sieve, rate-limiting resistance is dictated by ciliary muscle tone and extracellular matrix compactness.

Age-Related Decline: Accounts for up to 40 to 50 % 40\text{ to }50\% 40 to 50% of total drainage in pediatric eyes, but declines progressively to 10 to 20 % 10\text{ to }20\% 10 to 20% in elderly adults due to age-related sclerosis and densification of ciliary muscle connective tissue.

Pharmacological Modulation:

Prostaglandin Analogues (PGF2 α \alpha α agonists): Latanoprost, travoprost, tafluprost, and bimatoprost bind FP prostanoid receptors on ciliary smooth muscle cells. This triggers gene transcription and release of matrix metalloproteinases (MMP-1, MMP-3, and MMP-9) . These endopeptidases degrade inter-bundle type I and type III collagen fibrils, widening inter-muscular spaces and increasing uveoscleral outflow while treatment is effective.

Cycloplegics (Atropine, Cyclopentolate): Relax the ciliary muscle, widening interstitial spaces and augmenting uveoscleral outflow.

Cholinergic Agonists (Pilocarpine): Cause tonic contraction of the longitudinal ciliary muscle. While this pulls the scleral spur posteriorly to stretch open the trabecular meshwork (dramatically accelerating conventional outflow), it simultaneously compresses the ciliary muscle bundles, reducing uveoscleral flow.

3. Mathematical Modeling: The Goldmann Equation

In 1958, Hans Goldmann formulated the foundational steady-state hydrodynamic equation governing ocular fluid dynamics, modeling aqueous outflow as a modified electrical circuit obeying Ohm's law: P 0 = F − U C + P e P_0 = \frac{F - U}{C} + P_e P 0 ​ = C F − U ​ + P e ​

In classic clinical literature where unconventional uveoscleral flow ( U U U ) is negligible or aggregated into net facility, the formula is presented in its standard form: P 0 = F C + P e P_0 = \frac{F}{C} + P_e P 0 ​ = C F ​ + P e ​

where:

  • P 0 P_0 P 0 ​ = Steady-state Intraocular Pressure in millimetres of mercury ( mmHg \text{mmHg} mmHg )
  • F F F = Rate of aqueous humour synthesis (typically ≈ 2.5 μ L/min \approx 2.5\,\mu\text{L/min} ≈ 2.5 μ L/min )

U U U = Uveoscleral outflow rate (typically ≈ 0.2 to 0.5 μ L/min \approx 0.2\text{ to }0.5\,\mu\text{L/min} ≈ 0.2 to 0.5 μ L/min )

C C C = Conventional outflow facility (hydraulic conductance through the trabecular meshwork, expressed in μ L/min/mmHg \mu\text{L/min/mmHg} μ L/min/mmHg ; normal value ≈ 0.28 μ L/min/mmHg \approx 0.28\,\mu\text{L/min/mmHg} ≈ 0.28 μ L/min/mmHg )

P e P_e P e ​ = Episcleral venous pressure (typically ≈ 8 to 10 mmHg \approx 8\text{ to }10\text{ mmHg} ≈ 8 to 10 mmHg )

  • Worked Clinical Calculations
  • Example 1: Healthy Physiological Baseline

Calculate the steady-state intraocular pressure in a healthy individual with an aqueous synthesis rate F = 2.4 μ L/min F = 2.4\,\mu\text{L/min} F = 2.4 μ L/min , conventional outflow facility C = 0.24 μ L/min/mmHg C = 0.24\,\mu\text{L/min/mmHg} C = 0.24 μ L/min/mmHg , and episcleral venous pressure P e = 9 mmHg P_e = 9\text{ mmHg} P e ​ = 9 mmHg : P 0 = 2.4 0.24 + 9 = 10 + 9 = 19 mmHg P_0 = \frac{2.4}{0.24} + 9 = 10 + 9 = 19\text{ mmHg} P 0 ​ = 0.24 2.4 ​ + 9 = 10 + 9 = 19 mmHg

Example 2: Primary Open-Angle Glaucoma (Trabecular Sclerosis)

In primary open-angle glaucoma, extracellular matrix accumulation in the JCT reduces outflow facility ( C C C ) by 60 % 60\% 60% to 0.096 μ L/min/mmHg 0.096\,\mu\text{L/min/mmHg} 0.096 μ L/min/mmHg . Assuming F = 2.4 μ L/min F = 2.4\,\mu\text{L/min} F = 2.4 μ L/min and P e = 9 mmHg P_e = 9\text{ mmHg} P e ​ = 9 mmHg : P 0 = 2.4 0.096 + 9 = 25 + 9 = 34 mmHg P_0 = \frac{2.4}{0.096} + 9 = 25 + 9 = 34\text{ mmHg} P 0 ​ = 0.096 2.4 ​ + 9 = 25 + 9 = 34 mmHg

Example 3: Arteriovenous Malformation (Elevated Episcleral Venous Pressure)

A patient with a low-flow carotid-cavernous sinus dural fistula presents with engorged "corkscrew" episcleral veins and an elevated episcleral venous pressure P e = 22 mmHg P_e = 22\text{ mmHg} P e ​ = 22 mmHg . With normal outflow parameters ( F = 2.4 μ L/min F = 2.4\,\mu\text{L/min} F = 2.4 μ L/min , C = 0.24 μ L/min/mmHg C = 0.24\,\mu\text{L/min/mmHg} C = 0.24 μ L/min/mmHg ): P 0 = 2.4 0.24 + 22 = 10 + 22 = 32 mmHg P_0 = \frac{2.4}{0.24} + 22 = 10 + 22 = 32\text{ mmHg} P 0 ​ = 0.24 2.4 ​ + 22 = 10 + 22 = 32 mmHg

Important

The equation is a steady-state model. Episcleral pressure contributes to the predicted IOP but does not establish an absolute biological lower limit for every treatment. For numerical examples below using P = F / C + P e P=F/C+P_e P = F / C + P e ​ , assume unconventional flow is negligible or use F as net conventional flow; other parameters are held constant.